# N-Acetylglucosamine and Immunoglobulin Strengthen Gut Barrier Integrity via Complementary Microbiome Modulation

**Authors:** Emma De Beul, Jasmine Heyse, Michael Jurgelewicz, Aurélien Baudot, Lam Dai Vu, Pieter Van den Abbeele

PMC · DOI: 10.3390/nu18020210 · 2026-01-09

## TL;DR

N-Acetylglucosamine and immunoglobulin work together to improve gut health by balancing gut microbes and strengthening the gut barrier.

## Contribution

The study reveals complementary effects of SBI and NAG on gut microbiota and barrier function through combined microbiome modulation.

## Key findings

- SBI and NAG each improved gut barrier integrity, with the combination showing the strongest effect (+36% TEER).
- SBI increased propionate and indole derivatives, while NAG boosted acetate and butyrate, with the combination enhancing all three SCFAs.
- The combination of SBI and NAG increased microbial diversity and showed balanced modulation of gut microbiota.

## Abstract

Background: Gut barrier dysfunction and altered gut microbial metabolism are emerging signatures of chronic gut disorders. Considering growing interest in combining structurally and mechanistically distinct bioactives, we investigated the individual and combined effects of serum-derived bovine immunoglobulin (SBI) and N-acetylglucosamine (NAG) on the gut microbiome and barrier integrity. Methods: The validated ex vivo SIFR® (Systemic Intestinal Fermentation Research) technology, using microbiota from healthy adults (n = 6), was combined with a co-culture of epithelial/immune (Caco-2/THP-1) cells. Results: While SBI and NAG already significantly improved gut barrier integrity (TEER, transepithelial electrical resistance, +21% and +29%, respectively), the strongest effect was observed for SBI_NAG (+36%). This potent combined effect related to the observation that SBI and NAG each induced distinct, complementary shifts in microbial composition and metabolite output. SBI most selectively increased propionate (~Bacteroidota families) and health-associated indole derivatives (e.g., indole-3-propionic acid), while NAG most specifically boosted acetate and butyrate (~Bifidobacteriaceae, Ruminococcaceae, and Lachnospiraceae). The combination of SBI_NAG displayed effects of the individual ingredients, thus, for instance, enhancing all three short-chain fatty acids (SCFA) and elevating microbial diversity (CMS, community modulation score). Conclusions: Overall, SBI and NAG exert complementary, metabolically balanced effects on the gut microbiota, supporting combined use, particularly in individuals with gut barrier impairment or dysbiosis linked to lifestyle or early-stage gastrointestinal disorders.

## Linked entities

- **Chemicals:** N-Acetylglucosamine (PubChem CID 439174), propionate (PubChem CID 104745), indole-3-propionic acid (PubChem CID 3744), acetate (PubChem CID 175), butyrate (PubChem CID 104775)
- **Species:** Bacteroidota (taxon 976), Bifidobacteriaceae (taxon 31953), Lachnospiraceae (taxon 186803)

## Full-text entities

- **Diseases:** gastrointestinal disorders (MESH:D005767), gut disorders (MESH:C536735)
- **Chemicals:** acetate (MESH:D000085), SBI (-), indole (MESH:C030374), SCFA (MESH:D005232), butyrate (MESH:D002087), N-Acetylglucosamine (MESH:D000117), propionate (MESH:D011422)
- **Species:** gut metagenome (species) [taxon 749906]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12845043/full.md

---
Source: https://tomesphere.com/paper/PMC12845043